Lynx ophthalmoscope launches with FDA clearance, CE mark
Key takeaways:
- The Lynx pattern scanning laser indirect ophthalmoscope from Norlase received FDA clearance and a CE mark.
- The device allows surgeons to move freely during treatment.
Lynx, Norlase’s pattern scanning laser indirect ophthalmoscope, commercially launched with both FDA 510(k) clearance and a CE mark, according to a press release.
The ophthalmoscope, which includes an untethered laser and pattern module built into an ergonomic headset, is designed to allow surgeons to move freely during treatment. Features include a wireless user interface and multilingual voice control. In addition, Lynx is battery powered and includes simplyCLEAR safety filters for enhanced visualization as well as a full pattern palette, according to the release.
Lynx is the first pattern scanning laser indirect ophthalmoscope (LIO), the company said.
“With Lynx, pattern LIO is finally here,” Oliver Hvidt, CEO and co-founder of Norlase, said in the release. “Faster LIO treatments mean less ergonomic stress, more quality time with patients and more practice days that end on time.”
Read more about